Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

QJM: An International Journal of Medicine

Volumn 101, Issue 6, 2008, Pages 445-448

  Choudhry, M N ^a   Soran, H ^b   Ziglam, H M ^b  

^a Department of Musculoskeletal Medicine ^*  (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DRUG ABUSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENDOTOXIN DETECTION; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; INFECTION RISK; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICATION ERROR; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT DURATION;

EID: 44849131030     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn035     Document Type: Article

References (22)

1. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerging Infect Dis 2006; 12:409-15.
2. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004; 171:51-8.
3. Bignardi GE. Risk factors for Clostridium difficile infection. J. Hosp Infect 1998; 40:1-15.
4. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: A systematic review. J. Antimicrob Chemother 2003; 51:1339-50.
5. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23:653-9.
6. Pierce PF, Jr., Wilson R, Silva J, Jr, Garagusi VF, Rifkin GD, Fekely R, et al. Antibiotic-associated pseudomembranous colitis: An epidemiologic investigation of a cluster of cases. J Infect Dis 1982; 145:269-74.
7. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: A review. Clin Infect Dis 1993; 17 109-13.
8. Al-Tureihi FI, Hassoun A, Wolf-Klein G, Isenberg H. Albumin, length of stay, and proton pump inhibitors: Key factors in Clostridium difficile-associated disease in nursing home patients. J. Am. Med. Dir Assoc. 2005; 6:105-8.
9. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppresive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294: 2989-95.
10. Dial S, Alrasadi K, Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: Cohort and case-control studies. CMAJ 2004; 171:33-8.
11. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, et al A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006; 166:2518-24.
12. Williams C. Occurrence and significance of gastric colonization during acid-inhibitory theraphy. Best Practice Res 2001; 15:511-21.
13. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007; 102:2041-56; quiz 57.
14. Prescription Pricing Authority of United Kingdom and Wales. PPA annual report. 1999-2000.
15. Guidance on the Use of Proton Pump Inhibitors in the Treatment of Dyspepsia. [http://www.formulary.cht.nhs.uk/pdfdfeNGNPp]. Accessed July 2000.
16. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis 1993; 17:672-8.
17. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link Research Database. Br Med J (Clinical research ed. 1998; 317:452-6.
18. Sebastian SS, Kernan N, Quasim A, O'Morain CA, Buckley M. Appropriateness of gastric antisecretory therapy in hospital practice. Irish J Med Sci 2003; 172:115-7.
19. Brandhagen DJ, Pheley AM, Onstad GR, Freeman ML, Lurie N. Omeprazole use at an urban county teaching hospital. J Gen Intern Med 1995; 10 513-5.
20. Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: Perspective of patients and their GPs. Br J Gen Pract 2001; 51:703-11.
21. Raghunath AS, Hungin AP, Cornford CS, Featherstone V. Use of proton pump inhibitors: An exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion 2005; 72:12-8
22. McManus P, Marley J, Birkett DJ, Lindner J. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia. British J Clin Pharmacol 1998; 46:409-11.